Assays for hepatitis B surface antigen (HBsAg) are the most frequently used tests to detect HBV infection. Vaccination for HBV can produce transiently detectable levels of HBsAg in patients.

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

Following the landmark discovery in 1965 of the Australian antigen, subsequently renamed the hepatitis B surface antigen (HBsAg), Combes and coworkers first described the occurrence of membranous ...

A functional cure is said to have been achieved if a biomarker called hepatitis B surface antigen (HBsAg) is cleared from the blood and remains undetectable after stopping all treatment.

Use the purifier to isolate the hepatitis B antigen produced by the yeast cells. The vaccine, once administered, will stimulate the immune system to attack the antigen (i.e., the protein coat).

Inside the hepatocytes, HBV produces a surplus of viral antigens, including hepatitis B e antigen (HBeAg) and hepatitis B s antigen (HBsAg), which is HBV’s envelope protein. In addition to the ...

Hepatitis B surface antigen vaccine (recombinant) 5mcg/0.5mL; susp for IM inj; aluminum hydroxide adsorbed; preservative-free. Ped/Adolescent 5mcg/0.5mL: single-dose vials (yellow cap), single ...

Alliance Global Partners analyst James Molloy lowered the firm’s price target on Barinthus Biotherapeutics (BRNS) to $6 from $7.50 and keeps a ...